[GETECCU-2005 recommendations for the use of infliximab (Remicade) in inflammatory bowel disease].
Domènech
E
E
Servicio de Aparato Digestivo, Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain.
Esteve
M
M
Gomollón
F
F
Hinojosa
J
J
Panés
J
J
Obrador
A
A
Gassull
M A
MA
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D000069285:Infliximab
D000911:Antibodies, Monoclonal; D000069285:Infliximab